Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
86.89 USD
-1.24%
Market Closed
Updated:
May 28, 2024
Edwards Lifesciences Corp
Accrued Liabilities
|
Edwards Lifesciences Corp
Accrued Liabilities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accrued Liabilities
$24.8m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
See Also
What is Edwards Lifesciences Corp's Accrued Liabilities?
Accrued Liabilities
24.8m
USD
24.8m
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Accrued Liabilities amounts to 24.8m USD.
What is Edwards Lifesciences Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-44%
-44%
Over the last year, the Accrued Liabilities growth was -97%. The average annual Accrued Liabilities growth rates for Edwards Lifesciences Corp have been -64% over the past three years , -44% over the past five years .
You don't have any saved screeners yet
